| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 92.69B | 96.06B | 91.06B | 85.90B | 77.71B | 72.70B |
| Gross Profit | 20.37B | 21.16B | 20.13B | 19.41B | 17.38B | 16.85B |
| EBITDA | 2.80B | 2.88B | 2.77B | 2.89B | 2.15B | 2.46B |
| Net Income | 1.09B | 1.14B | 1.05B | 1.34B | 358.19M | 798.55M |
Balance Sheet | ||||||
| Total Assets | 23.68B | 25.14B | 24.33B | 23.90B | 22.22B | 21.59B |
| Cash, Cash Equivalents and Short-Term Investments | 3.99B | 4.72B | 4.78B | 4.90B | 3.51B | 3.62B |
| Total Debt | 3.11B | 3.21B | 3.34B | 4.00B | 5.09B | 4.68B |
| Total Liabilities | 12.02B | 13.00B | 13.13B | 13.54B | 13.14B | 12.73B |
| Stockholders Equity | 11.66B | 12.14B | 11.20B | 10.36B | 9.07B | 8.85B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.15B | 1.34B | 2.76B | 206.70M | 576.46M |
| Operating Cash Flow | 0.00 | 2.40B | 1.90B | 3.46B | 1.28B | 1.56B |
| Investing Cash Flow | 0.00 | -2.13B | -810.80M | -698.79M | -1.34B | -1.07B |
| Financing Cash Flow | 0.00 | -583.79M | -1.21B | -1.37B | -47.35M | 526.74M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥19.44B | 19.43 | ― | 2.12% | 12.42% | -6.09% | |
68 Neutral | ¥30.75B | 24.63 | ― | 2.22% | 19.03% | -8.80% | |
66 Neutral | ¥15.49B | -103.50 | ― | 1.48% | 5.48% | 9.22% | |
65 Neutral | ¥11.11B | 6.37 | ― | 1.45% | 0.95% | -14.50% | |
65 Neutral | ¥11.92B | 11.50 | ― | 2.30% | 4.72% | -1.87% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | ¥12.58B | 10.26 | ― | 2.32% | 2.78% | ― |